Combination of Usp7 knockdown and PI3K inhibition showed an additional cell growth impairment compared to PI3K-inhibitor-only treated cells; an effect that was most prominent in human breast cancer cells and upon use of PI3K-inhibitors at EC10 (Figure 6F). The gene discussed is PIK3CA; the disease is breast cancer.